Form 4: Elanco CEO Jeffrey Simmons Acquires Deferred Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


Elanco Animal Health CEO Jeffrey N. Simmons acquired 119.3805 deferred stock units as part of the company's executive compensation plan.

Summary

  • Jeffrey N. Simmons, President and CEO of Elanco Animal Health, acquired 119.3805 deferred stock units on April 17, 2026.
  • The units were acquired at a price of $23.68 per unit.
  • Following this transaction, the total number of deferred stock units beneficially owned by the CEO is 24,038.5303.
  • These units represent the right to receive common stock or cash equivalent upon termination of employment or at a specified future date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding executive compensation that does not indicate a change in company strategy or financial outlook.

Positives

  • Demonstrates continued alignment of executive interests with shareholders through participation in the Executive Deferral and Stock Match Plan.

Negatives

  • None identified.

Risks

  • Value of deferred stock units is subject to the future market performance of Elanco common stock.

Future Outlook

The deferred stock units will settle in cash or shares of common stock upon the reporting person's termination of employment or during a specified future year as per the company's deferral plan.

Industry Context

StockSavvy.ai notes that routine executive equity acquisitions via deferral plans are standard corporate governance practices in the pharmaceutical and animal health sectors, signaling internal confidence in long-term equity value.

Comparison to Industry Standards

  • The transaction aligns with standard executive compensation practices observed at peer companies like Zoetis and Merck Animal Health.
  • The use of deferred stock units is a common retention tool for C-suite executives in large-cap healthcare firms.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard executive compensation transaction.

Next Steps

  • The reporting person will continue to hold these units until the specified settlement conditions are met.

Key Dates

DateDescription
04/17/2026Date of the transaction involving deferred stock units.
04/21/2026Date the Form 4 was signed and filed.

Keywords

Elanco, ELAN, Insider Trading, Form 4, Executive Compensation, Jeffrey Simmons

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.